Rollman JE, Heyward J, Olson L, Lurie P, Sharfstein J, Alexander GC. JAMA. 2019;321:676-685.
Assessment of the FDA Risk Evaluation and Mitigation Strategy for transmucosal immediate-release fentanyl products.
Rollman JE, Heyward J, Olson L, Lurie P, Sharfstein J, Alexander GC. JAMA. 2019;321:676-685.